Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi

European Journal of Cancer

Volumn 40, Issue 9, 2004, Pages 1423-1430

  Pavel, Stan ^a   Van Nieuwpoort, Frans ^a   Van Der Meulen, Hans ^a   Out, Coby ^a   Pizinger, Karel ^b   Cetkovská, Petra ^b   Smit, Nico P M ^a   Koerten, Henk K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Calcium; Iron; Melanin; Melanoma; Naevus; Oxidative stress; X ray microanalysis

Indexed keywords

CALCIUM; IRON; MELANIN; OXYGEN RADICAL; RHODAMINE 123; SULFUR;

ARTICLE; CELL LABELING; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; DYSPLASTIC NEVUS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL; X RAY MICROANALYSIS;

CALCIUM; DYSPLASTIC NEVUS SYNDROME; ELECTRON PROBE MICROANALYSIS; FLOW CYTOMETRY; HUMANS; IRON; MELANINS; MELANOCYTES; MELANOMA; MICROSCOPY, FLUORESCENCE; NEVUS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 2942612282     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.11.035     Document Type: Article

References (43)

1. Augustsson A., Stierner U., Rosdahl I., Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm. Venereol. 71:1991;518-524
2. Bataille V., Bishop J.A., Sasieni P., et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer. 73:1996;1605-1611
3. Youl P., Aitken J., Hayward N., et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int. J. Cancer. 98:2002;92-98
4. Tucker M.A., Goldstein A.M. Melanoma etiology: where are we? Oncogene. 22:2003;3042-3052
5. Reimer R.R., Clark W.H. Jr., Greene M.H., Ainsworth A.M., Fraumeni J.F. Jr. Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA. 239:1978;744-746
6. Greene M.H., Clark W.H. Jr., Tucker M.A., et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N. Engl. J. Med. 312:1985;91-97
7. Elder D.E., Goldman L.I., Goldman S.C., Greene M.H., Clark W.H. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 46:1980;1787-1794
8. Weinstock M.A., Stryker W.S., Stampfer M.J., Lew R.A., Willett W.C., Sober A.J. Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study. Cancer. 67:1991;1701-1706
9. Hara K., Nitta Y., Ikeya T. Dysplastic nevus syndrome among Japanese. A case study and review of the Japanese literature. Am. J. Dermatopathol. 14:1992;24-31
10. Augustsson A., Stierner U., Suurkula M., Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br. J. Dermatol. 124:1991;152-156
11. Cooke K.R., Spears G.F., Elder D.E., Greene M.H. Dysplastic naevi in a population-based survey. Cancer. 63:1989;1240-1244
12. Sander C., Tschochohei H., Hagedorn M. Zur Epidemiologie des dysplastischen Nävus. Hautarzt. 40:1989;758-760
13. Crutcher W.A., Sagebiel R.W. Prevalence of dysplastic naevi in a community practice. Lancet. 1(8379):1984;729
14. Crijns M.B., Klaver C.C., De Boer A., et al. A comparative study of atypical and melanocytic naevi on the tropical island Curacao and in The Netherlands. Melanoma Res. 5:1995;161-167
15. Rhodes A.R., Seki Y., Fitzpatrick T.B., Stern R.S. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer. 61:1988;358-369
16. Salopek T.G., Yamada K., Ito S., Jimbow K. Dysplastic melanocytic nevi contain high levels of pheomelanin: quantitative comparison of pheomelanin/eumelanin levels between normal skin, common nevi, and dysplastic nevi. Pigment Cell Res. 4:1991;172-179
17. Cooksey C.J., Garratt P.J., Land E.J., Pavel S., Ramsden C.A., Riley P.A., et al. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J. Biol. Chem. 272:1997;26226-26235
18. Land E.J., Riley P.A. Spontaneous redox reactions of dopaquinone and the balance between the eumelanic and phaeomelanic pathways. Pigment Cell Res. 13:2000;273-277
19. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281:1991;9-19
20. Ermak G., Davies K.J. Calcium and oxidative stress: from cell signaling to cell death. Mol. Immunol. 38:2002;713-721
21. Rothe G., Oser A., Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften. 75:1988;354-355
22. Traupe H., Macher E., Hamm H., Happle R. Mutation rate estimates are not compatible with autosomal dominant inheritance of the dysplastic nevus "syndrome" Am. J. Med. Genet. 32:1989;155-157
23. Pawelek J.M., Lerner A.B. 5, 6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature. 276:1978;626-628
24. Borovansky J., Mirejovsky P., Riley P.A. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma. Neoplasma. 38:1991;393-400
25. Agrup G., Agrup P., Andersson T., et al. 5-S-Cysteinyldopa in the urine of melanoma patients. Acta Derm. Venereol. 57:1977;113-116
26. Pavel S., Elzinga H., Muskiet F.A., Smit J.M., Mulder N.H., Koops H.S. Eumelanin-related indolic compounds in the urine of treated melanoma patients. J. Clin. Chem. Clin. Biochem. 24:1986;167-173
27. 2+ transport by dopamine oxidation. Mol. Cell. Biochem. 201:1999;89-98
28. Lee C.S., Han J.H., Jang Y.Y., Song J.H., Han E.S. Differential effect of catecholamines and MPP (+) on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem. Int. 40:2002;361-369
29. Langer K., Rappersberger K., Steiner A., Konrad K., Wolff K. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi. Arch. Dermatol. Res. 282:1990;353-362
30. Henle E.S., Linn S. Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide. J. Biol. Chem. 272:1997;19095-19098
31. Pavel S., Smit N.P.M. Detoxification processes in pigment-producing cells. Hori Y., Hearing V., Nakayama J. Melanogenesis and malignant melanoma. 1996;161-168 Elsevier, Amsterdam
32. Tanaka M., Yoshida T., Okamoto K., Hirai S. Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes. Neuroreport. 10:1999;1883-1887
33. Lloyd D.R., Phillips D.H. Oxidative DNA damage mediated by copper (II), iron (II) and nickel (II) Fenton reactions: evidence for site-specific mechanisms in the formation of double-strand breaks, 8-hydroxydeoxyguanosine and putative intrastrand cross-links. Mutat. Res. 424:1999;23-36
34. Noz K.C., Bauwens M., Van Buul P.P., et al. Comet assay demonstrates a higher ultraviolet B sensitivity to DNA damage in dysplastic nevus cells than in common melanocytic nevus cells and foreskin melanocytes. J. Invest. Dermatol. 106:1996;1198-1202
35. Smit N.P.M., Van der Meulen J., Koerten H.K., et al. Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J. Invest. Dermatol. 109:1997;796-800
36. Smit N.P.M., Kolb R.M., Lentjes E.G.W.M., et al. Variations in melanin formation by cultured melanocytes from different skin types. Arch. Dermatol. Res. 290:1998;342-349
37. del Marmol V., Ito S., Bouchard B., et al. Cysteine deprivation promotes eumelanogenesis in human melanoma cells. J. Invest. Dermatol. 107:1996;698-702
38. Pavel S., Smit N.P.M., Van der Meulen J., et al. Homozygous germline mutation of the CDKN2A/p16 gene and G-6-PD deficiency in a multiple melanome case. Melanoma Res. 13:2003;171-178
39. Jurkiewicz B.A., Buettner G.R. Ultraviolet light-induced free radical formation in skin: an paramagnetic resonance study. Photochem. Photobiol. 59:1994;1-4
40. Kielbassa C., Roza L., Epe B. Wavelength dependence of oxidative DNA damage induced by UV and visible light. Carcinogenesis. 18:1997;811-816
41. Gniadecki R., Thorn T., Vicanova J., Petersen A., Wulf H.C. Role of mitochondria in ultraviolet-induced oxidative stress. J. Cell. Biochem. 80:2000;216-222
42. Pourzand C., Watkin R.D., Brown J.E., Tyrrell R.M. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc. Natl. Acad. Sci. USA. 96:1999;6751-6756
43. Kvam E., Hejmadi V., Ryter S., Pouzrand C., Tyrrell R.M. Heme oxygenase activity causes transient hypersensitivity to oxidative ultraviolet A radiation that depends on release of iron from heme. Free Radic. Biol. Med. 28:2000;1191-1196